Q1 2026: QuicksortRx Hits $334M in All-Time Savings

Fast Facts

• QuicksortRx customers saved a combined $40.4M in Q1 2026.

• The average customer saved $661.7K.

• The highest individual ROI this quarter hit 41x.

• Product swaps are the single biggest lever in pharmacy cost reduction.

• We grew from 46 to 61 health systems in just twelve months.

• For the second straight year, KLAS ranked us #1 for Purchasing Optimization Analytics.

Health systems entered 2026 under the same pressure they've faced for the past several years: drug costs climbing, margins shrinking, and finance teams demanding more accountability from every line of the pharmacy budget. Add in the uncertainty of CMS drug price negotiations, GPO compliance complexity, and HRSA's 340B rebate pilot, and pharmacy directors are navigating more moving parts than ever — with less and less room for error.

That's the environment in which QuicksortRx customers saved $40.4M in Q1 2026, up 17.57% from last quarter, and part of our $334M in all-time savings tracked across the platform. The headwinds are real. But so are our results.

From 46 to 61: The Growth Behind the Numbers

A year ago, we were working with 46 health systems. By the close of Q1 2026, that number stands at 61 — 15 new partners in twelve months. That's not just a customer count. It's 15 new pharmacy teams who are now getting clear answers about where their spend is going and what it's actually costing them. And the platform engagement data backs up that momentum — we logged 13,100 sessions in Q1, up 11% QoQ with an average session duration of 20 minutes.

$40.4M in Q1 Savings

The savings breakdown this quarter says as much about customer behavior as it does about the platform. Health systems that actively engage their data find the opportunities. Those that don't leave them on the table.

Product swaps dominated the quarter, driving 65.89% of total savings. That concentration isn't surprising. Most health systems are purchasing brand or higher-cost alternatives out of habit, outdated formulary decisions, or simply a lack of visibility into what's available. The actionable, real-time visibility we provide makes the opportunity immediate and significant — $26.5M saved in a single quarter is what happens when health systems can finally see what they’ve been missing.

What's more telling is what the rest of the savings breakdown represents. Contract optimization, accumulation fixes, and other initiatives collectively contributed more than a third of Q1 results — meaning customers aren't relying on a single strategy. They're working multiple angles simultaneously. That diversification is what’s helping push our all-time savings to $334M and keeps the trajectory moving quarter over quarter.

WAC Premium Performance Closes in on 2%

We achieved an average WAC premium of 3.63% across our customer base in Q1 2026, with a median of 2.69%. Our 2% Club — reserved for customers who maintain less than a 3% WAC premium over a rolling 90-day average for 30 consecutive days — now has 35 members, up 9 from Q1 2025.

The most notable movement this quarter: one health system reduced their WAC premium by 3.99%, dropping from 7.30% in January to 3.31% by March. That's not incremental improvement — that's a meaningful repositioning of an entire pharmacy program, and it happened in a single quarter.

Do you want to know your WAC Premium? Request a demo to find out today.

ROI That Holds Up in Any Budget Meeting

The average return across QuicksortRx customers this quarter was 19x. The highest individual ROI hit 41x.

Equally impressive is that getting to those returns doesn’t require a lengthy implementation and onboarding. Our Q1 launch times averaged 42 days, with the fastest launch this quarter coming in at 38 days. The quicker a health system is live, the sooner those returns start accumulating. And with SOC 2 Type II attestation and HIPAA compliance in place, health systems aren't trading speed for security to get there — a combination that matters when sensitive pricing and procurement data is on the line.

Best in KLAS. Again.

Savings numbers and ROI figures are compelling — but they carry even more weight when they're independently validated by the customers actually producing them. For the second consecutive year, KLAS ranked QuicksortRx the #1 product for Purchasing Optimization Analytics in the Best in KLAS Awards.

KLAS rankings are driven entirely by verified customer feedback, which means this recognition is a direct reflection of what pharmacy directors and health system leaders report when they're asked what's working. To hear what customers had to say or see the full report, visit quicksortrx.com/klas.

What’s New on the Platform

Two product updates shipped in Q1 worth knowing about.

The GPO Compliance Manager got a significant update this quarter, enhancing visibility across Vizient, Premier, and HealthTrust programs with more accurate unit-based compliance calculations in real time. As new GPO metrics take effect, these updates help pharmacy teams stay ahead of compliance requirements continuously and identify opportunities for improvement.

We also launched the Eli Lilly 340B Benefit Tool, which allows customers to rapidly project potential 340B savings losses by supplier based on current purchasing patterns. While Eli Lilly's claims-level data requirement has been postponed, the tool positions customers to be prepared when future supplier requirements do take effect.

What Would $661.7K Mean for Your Budget?

Sixty-one health systems are managing their pharmacy spend on QuicksortRx right now. Their average system savings in Q1 was $661.7k — in a single quarter. If your team is still working off static reports and manual contract tracking, the gap between what you're spending and what you could be spending is likely wider than you think.

Schedule a demo to see your potential savings numbers. You'll walk away with a clear picture where your pharmacy spend stands and exactly where it can go.